WHO Drug Information, Vol. 21, No. 3, 2007                                                 Recommended INN: List 58



International Nonproprietary Names for
Pharmaceutical Substances (INN)
RECOMMENDED International Nonproprietary Names:
List 58
Notice is hereby given that, in accordance with paragraph 7 of the Procedure for the Selection of Recommended
International Nonproprietary Names for Pharmaceutical Substances [Off. Rec. Wld Health Org., 1955, 60, 3 (Resolution
EB15.R7); 1969, 173, 10 (Resolution EB43.R9)], the following names are selected as Recommended International
Nonproprietary Names. The inclusion of a name in the lists of Recommended International Nonproprietary Names does not
imply any recommendation of the use of the substance in medicine or pharmacy.
Lists of Proposed (1–96) and Recommended (1–57) International Nonproprietary Names can be found in Cumulative List
No. 12, 2007 (available in CD-ROM only).



Dénominations communes internationales
des Substances pharmaceutiques (DCI)
Dénominations communes internationales RECOMMANDÉES:
Liste 58
Il est notifié que, conformément aux dispositions du paragraphe 7 de la Procédure à suivre en vue du choix de
Dénominations communes internationales recommandées pour les Substances pharmaceutiques [Actes off. Org. mond.
Santé, 1955, 60, 3 (résolution EB15.R7); 1969, 173, 10 (résolution EB43.R9)] les dénominations ci-dessous sont choisies
par l’Organisation mondiale de la Santé en tant que dénominations communes internationales recommandées. L’inclusion
d’une dénomination dans les listes de DCI recommandées n’implique aucune recommandation en vue de l’utilisation de la
substance correspondante en médecine ou en pharmacie.
On trouvera d’autres listes de Dénominations communes internationales proposées (1–96) et recommandées (1–57) dans
la Liste récapitulative No. 12, 2007 (disponible sur CD-ROM seulement).



Denominaciones Comunes Internacionales
para las Sustancias Farmacéuticas (DCI)
Denominaciones Comunes Internacionales RECOMENDADAS:
Lista 58
De conformidad con lo que dispone el párrafo 7 del Procedimiento de Selección de Denominaciones Comunes
Internacionales Recomendadas para las Sustancias Farmacéuticas [Act. Of. Mund. Salud, 1955, 60, 3 (Resolución
EB15.R7); 1969, 173, 10 (Resolución EB43.R9)], se comunica por el presente anuncio que las denominaciones que a
continuación se expresan han sido seleccionadas como Denominaciones Comunes Internacionales Recomendadas. La
inclusión de una denominación en las listas de las Denominaciones Comunes Recomendadas no supone recomendación
alguna en favor del empleo de la sustancia respectiva en medicina o en farmacia.
Las listas de Denominaciones Comunes Internacionales Propuestas (1–96) y Recomendadas (1–57) se encuentran
reunidas en Cumulative List No. 12, 2007 (disponible sólo en CD-ROM).




                                                                                                                   247
Recommended INN: List 58                                               WHO Drug Information, Vol. 21, No. 3, 2007




 Latin, English, French, Spanish:

 Recommended INN                    Chemical name or description; Molecular formula; Graphic formula

 DCI Recommandée                    Nom chimique ou description; Formule brute; Formule développée

 DCI Recomendada                    Nombre químico o descripción; Fórmula molecular; Fórmula desarrollada




 alogliptinum
 alogliptin                                2-({6-[(3R)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxo-
                                           3,4-dihydropyrimidin-1(2H)-yl}methyl)benzonitrile

 alogliptine                               2-({6-[(3R)-3-aminopipéridin-1-yl]-3-méthyl-2,4-dioxo-
                                           3,4-dihydropyrimidin-1(2H)-yl}méthyl)benzonitrile

 alogliptina                               2-({6-[(3R)-3-aminopiperidin-1-il]-3-metil-2,4-dioxo-
                                           3,4-dihidropirimidin-1(2H)-il}metil)benzonitrilo


                                           C18H21N5O2

                                                  H
                                            H2N

                                                      N           CN

                                                          N

                                              O       N       O
                                                      CH3




 alvespimycinum
 alvespimycin                              (4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-{[2-
                                           (dimethylamino)ethyl]amino}-13-hydroxy-8,14-dimethoxy-4,10,12,16-
                                           tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-
                                           1(21),4,6,10,18-pentaen-9-yl carbamate

 alvespimycine                             carbamate de (4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-{[2-
                                           (diméthylamino)éthyl]amino}-13-hydroxy-8,14-diméthoxy-4,10,12,16-
                                           tetraméthyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-
                                           1(21),4,6,10,18-pentaén-9-yle

 alvespimicina                             carbamato de (4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-[[2-
                                           (dimetilamino)etil]amino]-13-hidroxi-4,10,12,16-tetrametil-
                                           8,14-dimetoxi-3,20,22-trioxo-2-azabiciclo[16.3.1]docosa-
                                           1(21),4,6,10,18-pentaen-9-ilo




248
WHO Drug Information, Vol. 21, No. 3, 2007                                                      Recommended INN: List 58


                                             C32H48N4O8

                                                                                 CH3
                                                                        O
                                                                                       H
                                                             O              NH                      O       NH2
                                                   CH3                            H3CO
                                                                                                    H
                                                   N                            H3C                     O
                                             H3C             N              O HO H
                                                             H

                                                                    H     H   H
                                                                        CH3 OCH3 CH3


 amifampridinum
 amifampridine                               pyridine-3,4-diamine

 amifampridine                               pyridine-3,4-diamine

 amifampridina                               piridina-3,4-diamina

                                             C5H7N3

                                                       NH2
                                             N

                                                       NH2


 balamapimodum
 balamapimod                                 4-({3-chloro-4-[(1-methyl-1H-imidazol-2-yl)sulfanyl]phenyl}amino)-
                                             6-methoxy-7-[4-(pyrrolidin-1-yl)piperidin-1-yl]quinoline-3-carbonitrile

 balamapimod                                 4-({3-chloro-4-[(1-méthyl-1H-imidazol-2-yl)sulfanyl]phényl}amino]-
                                             6-méthoxy-7-[4-(pyrrolidin-1-yl)pipéridin-1-yl]quinoléine-3-carbonitrile

 balamapimod                                 4-({3-cloro-4-[(1-metil-1H-imidazol-2-il)sulfanil]fenil}amino]-6-metoxi-
                                             7-[4-(pirrolidin-1-il)piperidin-1-il]quinolina-3-carbonitrilo

                                             C30H32ClN7OS


                                                   N

                                                             N              N


                                                         H3CO                     CN
                                                                        HN                 Cl
                                                                                                N

                                                                                           S        N
                                                                                                    CH3


 bevirimatum
 bevirimat                                   3β-(3-carboxy-3-methylbutanoyloxy)lup-20(29)-en-28-oic acid

 bévirimat                                   acide 3β-(3-carboxy-3-méthylbutanoyloxy)lup-20(29)-én-28-oïque

 bevirimat                                   ácido 3β-(3-carboxi-3-metilbutanoiloxi)lup-20(29)-en-28-oico




                                                                                                                     249
Recommended INN: List 58                                WHO Drug Information, Vol. 21, No. 3, 2007


                           C36H56O6

                                                                            CH3
                                                                             H
                                                                 H2 C
                                                                        H

                                                        CH3       CH3           H       CO2H
                              H3C     CH3 O
                                              H              H          CH3
                           HO2C               O
                                              H3C     H
                                                    CH3


 carisbamatum
 carisbamate               (2S)-2-(2-chlorophenyl)-2-hydroxyethyl carbamate

 carisbamate               carbamate de (2S)-2-(2-chlorophényl)-2-hydroxyéthyle

 carisbamato               carbamato de (2S)-2-(2-clorofenil)-2-hidroxietilo

                           C9H10ClNO3

                                          H OH Cl
                           H2N        O

                                 O


 cevipabulinum
 cevipabulin               5-chloro-6-{2,6-difluoro-4-[3-(methylamino)propoxy]phenyl}-
                           N-[(1S)-1,1,1-trifluoropropan-2-yl][1,2,4]triazolo[1,5-a]pyrimidin-
                           7-amine

 cévipabuline              5-chloro-6-{2,6-difluoro-4-[3-(méthylamino)propoxy]phényl}-
                           N-[(1S)-1,1,1-trifluoropropan-2-yl][1,2,4]triazolo[1,5-a]pyrimidin-
                           7-amine

 cevipabulina              5-cloro-6-à2,6-difluoro-4-[3-(metilamino)propoxi]fenil}-
                           N-[(1S)-1,1,1-trifluoropropan-2-il][1,2,4]triazolo[1,5-a]pirimidin-
                           7-amina

                           C18H18ClF5N6O

                                                                        H       CH3
                                  H
                                  N           O               F
                           H3C                                    HN            CF3

                                                                                    N
                                                                            N
                                                    F
                                                        Cl         N                N


 dalcetrapibum
 dalcetrapib               S-{2-[1-(2-ethylbutyl)cyclohexanecarboxamido]=
                           phenyl} 2-methylpropanethioate

 dalcétrapib               2-méthylpropanethioate de S-[2-[[[1-(2-éthylbutyl)=
                           cyclohexanecarboxamido]phényle]

 dalcetrapib               2-metilpropanotioato de S-[2-[[[1-(2-etilbutil)=
                           ciclohexanocarboxamido]fenilo]



250
WHO Drug Information, Vol. 21, No. 3, 2007                                                    Recommended INN: List 58


                                             C23H35NO2S

                                                         O
                                             H3C                                    CH3
                                                             S
                                                                 H
                                                    CH3          N                    CH3

                                                                      O




 firategrastum
 firategrast                                 (2S)-2-(2,6-difluorobenzamido)-3-[4'-(ethoxymethyl)-2',6'-dimethoxy-
                                             [1,1'-biphenyl]-4-yl]propanoic acid

 firatégrast                                 acide (2S)-2-(2,6-difluorobenzamido)-3-[4'-(éthoxyméthyl)-
                                             2',6'-diméthoxy-[1,1’-biphényl]-4-yl]propanoïque

 firategrast                                 ácido (2S)-2-(2,6-difluorobenzamido)-3-[4'-(etoximetil)-2',6'-dimetoxi-
                                             [1,1'-bifenil]-4-il]propanoico

                                             C27H27F2NO6

                                                                     H3CO
                                                                                          O    CH3



                                                                              OCH3
                                                F        O
                                                                 H
                                                                      OH
                                                             N
                                                             H
                                                                 O
                                                         F



 giripladibum
 giripladib                                  4-{3-[5-chloro-1-(diphenylmethyl)-2-(2-{[2-(trifluoromethyl)=
                                             phenyl]methanesulfonamido}ethyl)-1H-indol-3-yl]propyl}benzoic acid

 giripladib                                  acide 4-{3-[5-chloro-1-(diphénylméthyl)-2-(2-{[2-(trifluoromethyl)=
                                             phényl]méthanesulfonamido}éthyl)-1H-indol-3-yl]propyl}benzoïque

 giripladib                                  ácido 4-{3-[5-cloro-1-(difenilmetil)-2-(2-{[2-(trifluorometil)fenil]=
                                             metanesulfonamido}etil)-1H-indol-3-il]propil}benzoico

                                             C41H36ClF3N2O4S

                                                                             F3 C

                                                                      O
                                                                     O S
                                                                        NH
                                                                                      CO2H
                                                             N




                                                    Cl




                                                                                                                     251
Recommended INN: List 58                                       WHO Drug Information, Vol. 21, No. 3, 2007


 imepitoinum
 imepitoin                    1-(4-chlorophenyl)-4-(morpholin-4-yl)-1,5-dihydro-2H-imidazol-2-one

 imépitoïne                   1-(4-chlorophényl)-4-(morpholin-4-yl)-1,5-dihydro-2H-imidazol-2-one

 imepitoina                   1-(4-clorofenil)-4-(morfolin-4-il)-1,5-dihidro-2H-imidazol-2-ona

                              C13H14ClN3O2

                                                   O
                                           N

                              O       N        N


                                                                    Cl



 isavuconazolum
 isavuconazole                4-{2-[(2R,3R)-3-(2,5-difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-
                              1-yl)butan-2-yl]-1,3-thiazol-4-yl}benzonitrile

 isavuconazole                4-{2-[(2R,3R)-3-(2,5-difluorophényl)-3-hydroxy-4-(1H-1,2,4-triazol-
                              1-yl)butan-2-yl]-1,3-thiazol-4-yl}benzonitrile

 isavuconazol                 4-{2-[(2R,3R)-3-(2,5-difluorofenil)-3-hidroxi-4-(1H-1,2,4-triazol-
                              1-il)butan-2-il]-1,3-tiazol-4-il}benzonitrilo

                              C22H17F2N5OS


                                                               F             F
                                                       S       HO

                              NC                   N
                                                           H    CH3 N
                                                                         N
                                                                    N



 isavuconazonii chloridum
 isavuconazonium chloride     1-{(2R,3R)-3-[4-(4-cyanophenyl)-1,3-thiazol-2-yl]-
                              2-(2,5-difluorophenyl)-2-hydroxybutyl}-4-{(1RS)-1-[methyl-
                              (3-{[(methylamino)acetyloxy]methyl}pyridin-2-yl)carbamoyloxy]ethyl}-
                              1,2,4-triazolium chloride

 chlorure d'isavuconazonium   chlorure de 1-{(2R,3R)-3-[4-(4-cyanophényl)-1,3-thiazol-2-yl]-
                              2-(2,5-difluorophényl)-2-hydroxybutyl}-4-{(1RS)-1-[méthyl-
                              (3-{[(méthylamino)acétyloxy]méthyl}pyridin-2-yl)carbamoyloxy]éthyl}-
                              1,2,4-triazolium

 cloruro de isavuconazonio    cloruro de 1-{(2R,3R)-3-[4-(4-cianofenil)-1,3-tiazol-2-il]-
                              2-(2,5-difluorofenil)-2-hidroxibutil}-4-{(1RS)-1-[metil-
                              (3-{[(metilamino)acetiloxi]metil}piridin-2-il)carbamoiloxi]etil}-
                              1,2,4-triazolium




252
WHO Drug Information, Vol. 21, No. 3, 2007                                                                Recommended INN: List 58


                                             C35H35ClF2N8O5S


                                                                                          F                F
                                                                                  S       HO

                                                    NC                        N
                                                                                                                and epimer at C*
                                                                                      H       CH3 N
                                                                                                                et l'épimère en C*
                                                                                                      N         y el epímero al C*
                                                                        N         O       H     N+        Cl-

                                                              O               N           O    * CH3
                                                    H
                                                    N                         CH3
                                              H3C                 O


 linaclotidum
 linaclotide                                 [9-L-tyrosine]heat-stable enterotoxin (Escherichia coli)-(6-19)-peptide

 linaclotide                                 [9-L-tyrosine]entérotoxine thermostable (Escherichia coli)-
                                             (6-19)-peptide

 linaclotida                                 [9-L-tirosina]enterotoxina termoestable (Escherichia coli)-
                                             (6-19)-péptido

                                             C59H79N15O21S6

                                              H Cys     Cys       Glu   Tyr    Cys        Cys     Asn     Pro

                                                 Ala     Cys      Thr   Gly    Cys        Tyr OH
                                                         10


 litenimodum
 litenimod                                   P-thiothymidylyl-(3'→5')-2'-deoxy-P-thioadenylyl-(3'→5')-2'-deoxy-
                                             P-thioadenylyl-(3'→5')-2'-deoxy-P-thioadenylyl-(3'→5')-2'-deoxy-
                                             P-thiocytidylyl-(3'→5')-2'-deoxy-P-thioguanylyl-(3'→5')-
                                             P-thiothymidylyl-(3'→5')-P-thiothymidylyl-(3'→5')-2'-deoxy-
                                             P-thioadenylyl-(3'→5')-P-thiothymidylyl-(3'→5')-2'-deoxy-
                                             P-thioadenylyl-(3'→5')-2'-deoxy-P-thioadenylyl-(3'→5')-2'-deoxy-
                                             P-thiocytidylyl-(3'→5')-2'-deoxy-P-thioguanylyl-(3'→5')-
                                             P-thiothymidylyl-(3'→5')-P-thiothymidylyl-(3'→5')-2'-deoxy-
                                             P-thioadenylyl-(3'→5')-P-thiothymidylyl-(3'→5')-2'-deoxy-
                                             P-thioguanylyl-(3'→5')-2'-deoxy-P-thioadenylyl-(3'→5')-2'-deoxy-
                                             P-thiocytidylyl-(3'→5')-2'-deoxy-P-thioguanylyl-(3'→5')-
                                             P-thiothymidylyl-(3'→5')-2'-deoxy-P-thiocytidylyl-(3'→5')-2'-deoxy-
                                             P-thioadenylyl-(3'→5')-thymidine

 liténimod                                   P-thiothymidylyl-(3'→5')-2'-désoxy-P-thioadénylyl-(3'→5')-2'-désoxy-
                                             P-thioadénylyl-(3'→5')-2'-désoxy-P-thioadénylyl-(3'→5')-2'-désoxy-
                                             P-thiocytidylyl-(3'→5')-2'-désoxy-P-thioguanylyl-(3'→5')-
                                             P-thiothymidylyl-(3'→5')-P-thiothymidylyl-(3'→5')-2'-désoxy-
                                             P-thioadénylyl-(3'→5')-P-thiothymidylyl-(3'→5')-2'-désoxy-
                                             P-thioadénylyl-(3'→5')-2'-désoxy-P-thioadénylyl-(3'→5')-2'-désoxy-
                                             P-thiocytidylyl-(3'→5')-2'-désoxy-P-thioguanylyl-(3'→5')-
                                             P-thiothymidylyl-(3'→5')-P-thiothymidylyl-(3'→5')-2'-désoxy-
                                             P-thioadénylyl-(3'→5')-P-thiothymidylyl-(3'→5')-2'-désoxy-
                                             P-thioguanylyl-(3'→5')-2'-désoxy-P-thioadénylyl-(3'→5')-2'-désoxy-
                                             P-thiocytidylyl-(3'→5')-2'-désoxy-P-thioguanylyl-(3'→5')-
                                             P-thiothymidylyl-(3'→5')-2'-désoxy-P-thiocytidylyl-(3'→5')-2'-désoxy-
                                             P-thioadénylyl-(3'→5')-thymidine


                                                                                                                                     253
Recommended INN: List 58                                  WHO Drug Information, Vol. 21, No. 3, 2007




 litenimod                   P-tiotimidilil-(3'→5')-2'-desoxi-P-tioadenilil-(3'→5')-2'-desoxi-
                             P-tioadenilil-(3'→5')-2'-desoxi-P-tioadenilil-(3'→5')-2'-desoxi-
                             P-tiocitidilil-(3'→5')-2'-desoxi-P-tioguanilil-(3'→5')-P-tiotimidilil-
                             (3'→5')-P-tiotimidilil-(3'→5')-2'-desoxi-P-tioadenilil-(3'→5')-
                             P-tiotimidilil-(3'→5')-2'-desoxi-P-tioadenilil-(3'→5')-2'-desoxi-
                             P-tioadenilil-(3'→5')-2'-desoxi-P-tiocitidilil-(3'→5')-2'-desoxi-
                             P-tioguanilil-(3'→5')-P-tiotimidilil-(3'→5')-P-tiotimidilil-(3'→5')-
                             2'-desoxi-P-tioadenilil-(3'→5')-P-tiotimidilil-(3'→5')-2'-desoxi-
                             P-tioguanilil-(3'→5')-2'-desoxi-P-tioadenilil-(3'→5')-2'-desoxi-
                             P-tiocitidilil-(3'→5')-2'-desoxi-P-tioguanilil-(3'→5')-P-tiotimidill-(3'→5')-
                             2'-desoxi-P-tiocitidilil-(3'→5')-2'-desoxi-P-tioadenilil-(3'→5')-timidina

                             C256H322N95O129P25S25

                             (3'-5')d(P-thio) (T A A A C G T T A T A A C
                                                 G T T A T G A C G T C A T)


 managlinatum dialanetilum
 managlinat dialanetil       diethyl N,N'-{5-[2-amino-5-(2-methylpropyl)-1,3-thiazol-4-yl]furan-
                             2-ylphosphonoyl}di-L-alaninate

 managlinat dialanétil       N,N'-{5-[2-amino-5-(2-méthylpropyl)-1,3-thiazol-4-yl]furan-
                             2-ylphosphonoyl}di-L-alaninate de diéthyle

 managlinat dialanetilo      N,N'-{5-[2-amino-5-(2-metilpropil)-1,3-tiazol-4-il]furan-2-ilfosfonoil}=
                             di-L-alaninato de dietilo

                             C21H33N4O6PS

                                     H2N
                                                         O       O         CH3
                                             N
                                         S                        H
                                                    O   HN
                             H 3C                                CH3
                                                          P
                                                            NH
                                                        O
                               H3C                       H             O     CH3
                                                        H3C
                                                                 O


 masitinibum
 masitinib                   4-[(4-methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)-
                             1,3-thiazol-2-yl]amino}phenyl)benzamide

 masitinib                   4-[(4-méthylpipérazin-1-yl)méthyl]-N-(4-méthyl-3-{[4-(pyridin-3-yl)-
                             1,3-thiazol-2-yl]amino}phényl)benzamide

 masitinib                   4-[(4-metilpiperazin-1-il)metil]-N-(4-metil-3-{[4-(piridin-3-il)-1,3-tiazol-
                             2-il]amino}fenil)benzamida

                             C28H30N6OS

                                             N
                                                                 H               H
                                     N                           N               N      N
                             H3C
                                                             O                      S        N
                                                                                 CH3




254
WHO Drug Information, Vol. 21, No. 3, 2007                                                  Recommended INN: List 58




 methylnaltrexonii bromidum
 methylnaltrexone bromide                    (17S)-17-(cyclopropylmethyl)-4,5α-epoxy-3,14-dihydroxy-17-methyl-
                                             6-oxo-14β-morphinanium bromide

 bromure de méthylnaltrexone                 bromure de (17RS)-17-(cyclopropylméthyl)-4,5α-époxy-
                                             3,14-dihydroxy-17-méthyl-6-oxomorphinanium

 bromuro de metilnaltrexona                  bromuro de (17RS)-17-(ciclopropilmetil)-4,5α-epoxi-3,14-dihidroxi-
                                             17-metil-6-oxomorfinanio

                                             C21H26BrNO4

                                                                CH3
                                                       H   N+
                                                                          and epimer at N+
                                                      HO              Br- et l'épimère en N
                                                                                            +

                                                                          y el epímero al N+

                                              HO       O         O
                                                           H




 naptumomabum estafenatoxum*
 naptumomab estafenatox                      immunoglobulin fragment, anti-[trophoblast glycoprotein (TPBG,
                                             5T4)] monoclonal 5T4 gamma1 heavy chain fragment fusion protein
                                             [Mus musculus VH (5T4V14: H41>P, S44>G, I69>T, V113>G)-
                                             IGHG1_CH1)] - [Glycyl-Glycyl-Prolyl] - superantigen SEA/E-120
                                             (synthetic), non-disulfide linked with monoclonal 5T4 kappa light
                                             chain [Mus musculus V-KAPPA (5T4V18: F10>S, T45>K, I63>S,
                                             F73>L, T77>S, L78>V, L83>A)-IGKC]

 naptumomab estafénatox                      immunoglobuline fragment, anti-[glycoprotéine du trophoblaste
                                             (TPBG, 5T4)] protéine de fusion du fragment de la chaîne lourde
                                             gamma1 du monoclonal 5T4 [Mus musculus VH (5T4V14: H41>P,
                                             S44>G, I69>T, V113>G)-IGHG1_CH1)]- [Glycyl-Glycyl-Prolyl] -
                                             superantigène SEA/E-120 (synthétique), associée de manière non
                                             covalente à la chaîne légère kappa du monoclonal 5T4 [Mus
                                             musculus V-KAPPA (5T4V18: F10>S, T45>K, I63>S, F73>L, T77>S,
                                             L78>V, L83>A)-IGKC]

 naptumomab estafenatox                      fragmento de inmunoglobulina, anti-[glicoproteína de trofoblasto
                                             (TPBG, 5T4)] proteína de fusión del fragmento de la cadena pesada
                                             gamma1 del monoclonal 5T4 [Mus musculus VH (5T4V14: H41>P,
                                             S44>G, I69>T, V113>G)-IGHG1_CH1)] - [Glicil-Glicil-Prolil]–
                                             superantígeno SEA/E-120 (sintético), asociada no covalentemente a
                                             la cadena ligera kappa del monoclonal 5T4 [Mus musculus V-
                                             KAPPA (5T4V18: F10>S, T45>K, I63>S, F73>L, T77>S, L78>V,
                                             L83>A)-IGKC]




                                                                                                                  255
Recommended INN: List 58                                     WHO Drug Information, Vol. 21, No. 3, 2007


                           C3255H5025N855O1050S18

                           Heavy chain GGP toxin / Chaîne lourde GGP toxine / Cadena pesada GGP toxina
                           EVQLQQSGPD LVKPGASVKI SCKASGYSFT GYYMHWVKQS PGKGLEWIGR                            50
                           INPNNGVTLY NQKFKDKATL TVDKSSTTAY MELRSLTSED SAVYYCARST                            100
                           MITNYVMDYW GQGTSVTVSS AKTTPPSVYP LAPGSAAQTN SMVTLGCLVK                            150
                           GYFPEPVTVT WNSGSLSSGV HTFPAVLQSD LYTLSSSVTV PSSTWPSETV                            200
                           TCNVAHPASS TKVDKKIVPR DSGGPSEKSE EINEKDLRKK SELQGTALGN                            250
                           LKQIYYYNSK AITSSEKSAD QFLTNTLLFK GFFTGHPWYN DLLVDLGSTA                            300
                           ATSEYEGSSV DLYGAYYGYQ CAGGTPNKTA CMYGGVTLHD NNRLTEEKKV                            350
                           PINLWIDGKQ TTVPIDKVKT SKKEVTVQEL DLQARHYLHG KFGLYNSDSF                            400
                           GGKVQRGLIV FHSSEGSTVS YDLFDAQGQY PDTLLRIYRD NTTISSTSLS                            450
                           ISLYLYTT                                                                    458

                           Light chain / Chaîne légère / Cadena ligera
                           SIVMTQTPTS LLVSAGDRVT ITCKASQSVS                    NDVAWYQQKP       GQSPKLLISY   50'
                           TSSRYAGVPD RFSGSGYGTD FTLTISSVQA                    EDAAVYFCQQ       DYNSPPTFGG   100'
                           GTKLEIKRAD AAPTVSIFPP SSEQLTSGGA                    SVVCFLNNFY       PKDINVKWKI   150'
                           DGSERQNGVL NSWTDQDSKD STYSMSSTLT                    LTKDEYERHN       SYTCEATHKT   200'
                           STSPIVKSFN RNES                                                                   214'

                           Disulfide bridges location / Position des ponts disulfure /
                           Posiciones de los puentes disulfuro
                           22-96 23'-88' 134'-194' 147-202 321-331




 nemonoxacinum
 nemonoxacin               7-[(3S,5S)-3-amino-5-methylpiperidin-1-yl]-1-cyclopropyl-8-methoxy-
                           4-oxo-1,4-dihydroquinoline-3-carboxylic acid

 némonoxacine              acide 7-[(3S,5S)-3-amino-5-méthylpipéridin-1-yl]-1-cyclopropyl-
                           8-méthoxy-4-oxo-1,4-dihydroquinoléine-3-carboxylique

 nemonoxacino              ácido 7-[(3S,5S)-3-amino-5-metilpiperidin-1-il]-1-ciclopropil-8-metoxi-
                           4-oxo-1,4-dihidroquinolina-3-carboxílico

                           C20H25N3O4

                                     H CH3

                                                     OCH3
                           H2N             N                N
                                 H
                                                                   CO2H
                                                            O



 obinepitidum
 obinepitide               [34-L-glutamine]pancreatic hormone (human)

 obinépitide               [34-L-glutamine]hormone pancréatique humaine

 obinepitida               [34-L-glutamina]hormona pancreática humana

                           C185H288N54O55S2

                           H Ala     Pro   Leu       Glu    Pro   Val   Tyr   Pro Gly     Asp    Asn   Ala
                                                                                          10
                              Thr    Pro   Glu       Gln Met      Ala   Gln   Tyr   Ala   Ala   Asp    Leu
                                                                              20
                              Arg    Arg       Tyr   Ile   Asn    Met   Leu   Thr   Arg   Gln    Arg   Tyr NH2
                                                                  30




256
WHO Drug Information, Vol. 21, No. 3, 2007                                                          Recommended INN: List 58


 ozenoxacinum
 ozenoxacin                                  1-cyclopropyl-8-methyl-7-[5-methyl-6-(methylamino)pyridin-3-yl]-
                                             4-oxo-1,4-dihydroquinoline-3-carboxylic acid

 ozénoxacine                                 acide 1-cyclopropyl-8-méthyl-7-[5-méthyl-6-(méthylamino)pyridin-
                                             3-yl]-4-oxo-1,4-dihydroquinoléine-3-carboxylique

 ozenoxacino                                 ácido 1-ciclopropil-7-[5-metil-6-(metilamino)piridin-3-il]-8-metil-4-oxo-
                                             1,4-dihidroquinolina-3-carboxílico

                                             C21H21N3O3

                                                     H
                                                     N       N
                                             H3C                       CH3
                                                                                 N
                                                H3C

                                                                                          CO2H
                                                                                 O



 padeliporfinum
 padeliporfin                                dihydrogen (3-{(7S,8S,17R,18R)-13-acetyl-18-ethyl-5-(-2-methoxy-
                                             2-oxoethyl)-2,8,12,17-tetramethyl-3-[(2-sulfonatoethyl)carbamoyl]-
                                             7,8,17,18-tetrahydroporphyrin-7-yl}propanoato)palladium

 padéliporfine                               dihydrogéno(3-{(7S,8S,17R,18R)-13-acétyl-18-éthyl-5-(2-méthoxy-
                                             2-oxoéthyl)-2,8,12,17-tétraméthyl-3-[(2-sulfonatoéthyl)carbamoyl]-
                                             7,8,17,18-tétrahydroporphirin-7-yl}propanoato)palladium

 padeliporfina                               dihidrógeno(3-{(7S,8S,17R,18R)-13-acetil-18-etil-5-(2-metoxi-
                                             2-oxoetil)-2,8,12,17-tetrametil-3-[(2-sulfonatoetil)carbamoil]-
                                             7,8,17,18-tetrahidroporfirin-7-il}propanoato)paladio

                                             C37H43N5O9PdS

                                                       H3C             H CH
                                                                           3
                                             H3C                                          CO2H
                                                                                  O
                                               O             N         N         H        O
                                                                 Pd                           CH3
                                                             N         N              O
                                               H3C
                                                   H                                             SO3H
                                                                                 HN
                                                         H                 CH3
                                                                 CH3




 pamapimodum
 pamapimod                                   6-(2,4-difluorophenoxy)-2-[(1,5-dihydroxypentan-3-yl)amino]-
                                             8-methylpyrido[2,3-d]pyrimidin-7(8H)-one

 pamapimod                                   6-(2,4-difluorophénoxy)-2-[(1,5-dihydroxypentan-3-yl)amino]-
                                             8-méthylpyrido[2,3-d]pyrimidin-7(8H)-one

 pamapimod                                   6-(2,4-difluorofenoxi)-2-[(1,5-dihidroxipentan-3-il)amino]-
                                             8-metilpirido[2,3-d]pirimidin-7(8H)-ona




                                                                                                                         257
Recommended INN: List 58                                  WHO Drug Information, Vol. 21, No. 3, 2007


                           C19H20F2N4O4

                                     OH                              F
                                                                O
                                                N

                           HO              N        N     N     O            F
                                           H
                                                          CH3



 panobinostatum
 panobinostat              (2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-
                           3-yl)ethyl]amino}methyl)phenyl]prop-2-enamide

 panobinostat              (2E)-N-hydroxy-3-[4-({[2-(2-méthyl-1H-indol-
                           3-yl)éthyl]amino}méthyl)phényl]prop-2-énamide

 panobinostat              (2E)-N-hidroxi-3-[4-({[2-(2-metil-1H-indol-
                           3-il)etil]amino}metil)fenil]prop-2-enamida

                           C21H23N3O2

                                          CH3
                                HN

                                                    N
                                                    H                        H
                                                                             N
                                                                                 OH
                                                                         O



 pardoprunoxum
 pardoprunox               7-(4-methylpiperazin-1-yl)-1,3-benzoxazol-2(3H)-one

 pardoprunox               7-(4-méthylpipérazin-1-yl)-1,3-benzoxazol-2(3H)-one

 pardoprunox               7-(4-metilpiperazin-1-il)-1,3-benzoxazol-2(3H)-ona

                           C12H15N3O2




                           HN              N
                                  O                 N
                                                        CH3
                            O



 resatorvidum
 resatorvid                ethyl (6R)-6-[(2-chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-
                           1-carboxylate

 résatorvid                (6R)-6-[(2-chloro-4-fluorophényl)sulfamoyl]cyclohex-1-ène-
                           1-carboxylate d’éthyle

 resatorvid                (6R)-6-[(2-cloro-4-fluorofenil)sulfamoil]ciclohex-1-eno-1-carboxilato
                           de etilo




258
WHO Drug Information, Vol. 21, No. 3, 2007                                                          Recommended INN: List 58


                                             C15H17ClFNO4S

                                             F                      O       O     CH3
                                                                 O O
                                                                  S
                                                                N
                                                                H H
                                                     Cl




 rusalatidum
 rusalatide                                  human prothrombin-(508-530)-peptidamide (thrombin heavy chain
                                             fragment (TRAP 508))

 rusalatide                                  prothrombine humaine-(508-530)-peptidamide (fragment de la
                                             chaîne lourde de la thrombine (TRAP 508))

 rusalatida                                  protrombina humana-(508-530)-peptidamida (fragmento de la
                                             cadena pesada de la trombina (TRAP 508))

                                             C97H147N29O35S

                                             H Ala        Gly   Tyr   Lys   Pro   Asp   Glu   Gly    Lys    Arg   Gly   Asp
                                                                                                            10
                                                 Ala Cys        Glu   Gly   Asp   Ser   Gly   Gly     Pro   Phe   Val NH2
                                                                                               20




 senicapocum
 senicapoc                                   2,2-bis(4-fluorophenyl)-2-phenylacetamide

 sénicapoc                                   2,2-bis(4-fluorophényl)-2-phénylacétamide

 senicapoc                                   2-fenil-2,2-bis(4-fluorofenil)acetamida

                                             C20H15F2NO

                                             F
                                                                 O

                                                                      NH2



                                                 F



 tanespimycinum
 tanespimycin                                (4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-
                                             4,10,12,16-tetramethyl-3,20,22-trioxo-19-[(prop-2-en-1-yl)amino]-
                                             2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate

 tanespimycine                               carbamate de (4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-
                                             8,14-diméthoxy-4,10,12,16-tétraméthyl-3,20,22-trioxo-19-[(prop-
                                             2-én-1-yl)amino]-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-
                                             pentaén-9-yle

 tanespimicina                               carbamato de (4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hidroxi-
                                             8,14-dimetoxi-4,10,12,16-tetrametil-3,20,22-trioxo-19-[(prop-2-en-
                                             1-il)amino]-2-azabiciclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-ilo




                                                                                                                              259
Recommended INN: List 58                                           WHO Drug Information, Vol. 21, No. 3, 2007


                           C31H43N3O8

                                                                     CH3
                                                           O
                                                                            H
                                           O                   NH                          O         NH2
                                                                      H3CO
                                                                                           H
                           H2C                                     H3C                         O
                                           N                   O HO H
                                           H

                                                     H       H   H
                                                           CH3 OCH3 CH3


 telatinibum
 telatinib                 4-[({4-[(4-chlorophenyl)amino]furo[2,3-d]pyridazin-7-yl}oxy)methyl]-
                           N-methylpyridine-2-carboxamide

 télatinib                 4-[({4-[(4-chlorophényl)amino]furo[2,3-d]pyridazin-7-yl}oxy)méthyl]-
                           N-méthylpyridine-2-carboxamide

 telatinib                 4-[({4-[(4-clorofenil)amino]furo[2,3-d]piridazin-7-il}oxi)metil]-
                           N-metilpiridina-2-carboxamida

                           C20H16ClN5O3

                                                                                 H
                                                               O                 N
                                      O
                           H3C                                              N
                                 N                             O       N                             Cl
                                 H
                                           N


 tesamorelinum
 tesamorelin               (3E)-hex-3-enoylsomatoliberin (human GHRH)

 tésamoréline              (3E)-hex-3-enoylsomatolibérine humaine

 tesamorelina              (3E)-hex-3-enoilsomatoliberina humana

                           C221H366N72O67S

                             O
                                     Tyr   Ala       Asp       Ala    Ile   Phe      Thr       Asn    Ser       Tyr   Arg   Lys
                                                                                                                10
                                     Val   Leu       Gly       Gln    Leu    Ser      Ala      Arg        Lys   Leu   Leu   Gln
                                                                                                20
                                     Asp       Ile   Met       Ser    Arg    Gln     Gln       Gly    Glu       Ser   Asn   Gln
                                                                                30

                           H3C       Glu   Arg       Gly       Ala    Arg   Ala      Arg       Leu NH2
                                                               40


 ulipristalum
 ulipristal                11β-[4-(dimethylamino)phenyl]-17-hydroxy-19-norpregna-4,9-diene-
                           3,20-dione

 ulipristal                11β-[4-(diméthylamino)phényl]-17-hydroxy-19-norprégna-4,9-diène-
                           3,20-dione

 ulipristal                11β-[4-(dimetilamino)fenil]-17-hidroxi-19-norpregna-4,9-dieno-
                           3,20-diona



260
WHO Drug Information, Vol. 21, No. 3, 2007                                                                  Recommended INN: List 58


                                             C28H35NO3

                                                    CH3
                                                    N                             O
                                             H3C                                          CH3
                                                                      H       CH3
                                                                                          OH
                                                                          H

                                                                              H
                                                    O


 vernakalantum
 vernakalant                                 (3R)-1-{(1R,2R)-2-[2-(3,4-dimethoxyphenyl)ethoxy]=
                                             cyclohexyl}pyrrolidin-3-ol

 vernakalant                                 (3R)-1-{(1R,2R)-2-[2-(3,4-diméthoxyphényl)éthoxy]=
                                             cyclohexyl}pyrrolidin-3-ol

 vernakalant                                 (3R)-1-{(1R,2R)-2-[2-(3,4-dimetoxifenil)etoxi]ciclohexil}pirrolidin-3-ol

                                             C20H31NO4

                                             H3CO


                                             H3CO                             O           N            OH
                                                                                  H   H                H


 votucalisum*
 votucalis                                   methionyl[145-leucine]FS-HBP2 (Rhipicephalus appendiculatus
                                             (Brown ear tick) Female-Specific Histamine-Bending Protein 2)

 votucalis                                   méthionyl[145-leucine]FS-HBP2 (Protéine 2 se liant à l’histamine
                                             spécifique à la tique femelle Rhipicephalus appendiculatus)

 votucalis                                   metionil[145-leucina]FS-HBP2 (Proteína 2 que se une a la histamina
                                             específica de la garrapata hembra Rhipicephalus appendiculatus)

                                             C858H1259N221O289S10

                                                                                                                                  M
                                              NQPDWADEAA          NGAHQDAWKS          LKADVENVYY            MVKATYKNDP   VWGNDFTCVG    50
                                              VMANDVNEDE          KSIQAEFLFM          NNADTNMQFA            TEKVTAVKMY   GYNRENAFRY   100
                                              ETEDGQVFTD          VIAYSDDNCD          VIYVPGTDGN            EEGYELWTTD   YDNILANCLN   150
                                              KFNEYAVGRE          TRDVFTSACL          E                                               171
                                              Disulfide bridges location / Position des ponts disulfure /
                                              Posiciones de los puentes disulfuro
                                                   48-169             119-148




                                                                                                                                      261
Recommended INN: List 58                                                     WHO Drug Information, Vol. 21, No. 3, 2007




                           AMENDMENTS TO PREVIOUS LISTS
                   MODIFICATIONS APPORTÉES AUX LISTES ANTÉRIEURES
                       MODIFICACIONES A LAS LISTAS ANTERIORES


Recommended International Nonproprietary Names (Rec. INN): List 14
(WHO Chronicle, Vol. 28, No. 10, 1974)

p. 4   dimemorfanum
       dimemorfan                    insert the following graphic formula:

                                                        CH3
                                                H   N

                                                H



                                     H3C




Dénominations communes internationales recommandées (DCI Rec.): Liste 14
(Chronique OMS, Vol. 28, No. 10, 1974)

p. 4   dimemorfanum
       dimémorfane                   insérer la formule développée suivante:

                                                        CH3
                                                H   N

                                                H



                                     H3C



Denominaciones Comunes Internacionales Recomendadas (DCI Rec.): Lista 14
(Crónica de la OMS, Vol. 28, No. 10, 1974)

p. 4   dimemorfanum
       dimemorfano                   insértese la formúla désarollada siguiente:

                                                        CH3
                                                H   N

                                                H



                                     H3C




262
WHO Drug Information, Vol. 21, No. 3, 2007                                 Recommended INN: List 58




Recommended International Nonproprietary Names (Rec. INN): List 34
Dénominations communes internationales recommandées (DCI Rec.): Liste 34
Denominaciones Comunes Internacionales Recomendadas (DCI Rec.): Lista 34
(WHO Drug Information, Vol. 8, No. 3, 1994)

p. 167    suprimáse                     insértese
          afovirseno                    afovirsén



Recommended International Nonproprietary Names (Rec. INN): List 37
Dénominations communes internationales recommandées (DCI Rec.): Liste 37
Denominaciones Comunes Internacionales Recomendadas (DCI Rec.): Lista 37
(WHO Drug Information, Vol. 11, No. 1, 1997)

p. 41    suprimáse                      insértese
         fomivirseno                    fomivirsén



Recommended International Nonproprietary Names (Rec. INN): List 39
Dénominations communes internationales recommandées (DCI Rec.): Liste 39
Denominaciones Comunes Internacionales Recomendadas (DCI Rec.): Lista 39
(WHO Drug Information, Vol. 12, No. 1, 1998)

p. 57    suprimáse                      insértese
         trecovirseno                   trecovirsén



Recommended International Nonproprietary Names (Rec. INN): List 47
Dénominations communes internationales recommandées (DCI Rec.): Liste 47
Denominaciones Comunes Internacionales Recomendadas (DCI Rec.): Lista 47
(WHO Drug Information, Vol. 16, No. 1, 2002)

p. 84    suprimáse                      insértese
         alicaforseno                   alicaforsén



Recommended International Nonproprietary Names (Rec. INN): List 49
Dénominations communes internationales recommandées (DCI Rec.): Liste 49
Denominaciones Comunes Internacionales Recomendadas (DCI Rec.): Lista 49
(WHO Drug Information, Vol. 17, No. 2, 2003)

p. 129    suprimáse                     insértese
          oblimerseno                   oblimersén



Recommended International Nonproprietary Names (Rec. INN): List 51
Dénominations communes internationales recommandées (DCI Rec.): Liste 51
Denominaciones Comunes Internacionales Recomendadas (DCI Rec.): Lista 51
(WHO Drug Information, Vol. 18, No. 1, 2004)

p. 85    suprimáse                      insértese
         aprinocarseno                  aprinocarsén




                                                                                                263
 Recommended INN: List 58                                                     WHO Drug Information, Vol. 21, No. 3, 2007




 Recommended International Nonproprietary Names (Rec. INN): List 57
 Dénominations communes internationales recommandées (DCI Rec.): Liste 57
 Denominaciones Comunes Internacionales Recomendadas (DCI Rec.): Lista 57
 (WHO Drug Information, Vol. 21, No. 1, 2007)

 p. 55   aclidinii bromidum
         bromuro de aclidinio           sustitúyase el nombre químico por el siguiente:

                                        bromuro de (3R)-1-(3-fenoxipropil)-3-[(hidroxibis(tiofen-2-il)acetiloxi)]-1-2-butil-
                                                                                 5
                                        3-{4-[3-(dibutilamino)propil]benzoil}- 1λ -azabiciclo[2.2.2]octan-1-ilio




 * Electronic structure available on Mednet: http://mednet.who.int/
 * Structure électronique disponible sur Mednet: http://mednet.who.int/
 * Estructura electrónica disponible en Mednet: http://mednet.who.int/




Procedure and Guiding Principles / Procédure et Directives / Procedimientos y principios generales
The text of the Procedures for the Selection of Recommended International Nonproprietary Names for Pharmaceutical
Substances and General Principles for Guidance in Devising International Nonproprietary Names for Pharmaceutical
Substances will be reproduced in proposed INN lists only.
Les textes de la Procédure à suivre en vue du choix de dénominations communes internationales recommandées pour les
substances pharmaceutiques et des Directives générales pour la formation de dénominations communes internationales
applicables aux substances pharmaceutiques seront publiés seulement dans les listes des DCI proposées.
El texto de los Procedimientos de selección de denominaciones comunes internacionales recomendadas para las sustancias
farmacéuticas y de los Principios generales de orientación para formar denominaciones comunes internacionales para
sustancias farmacéuticas aparece solamente en las listas de DCI propuestas.




 264
